Smad3 mutant mice develop metastatic colorectal cancer

Cell

Volumn 94, Issue 6, 1998, Pages 703-714

  Yuan, Zhu ^a   Richardson, James A ^b   Parada, Luis F ^a   Graft, Jonathan M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MUTANT PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; LYMPH NODE METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM PROLAPSE; SIGNAL TRANSDUCTION;

EID: 0032544448     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81730-4     Document Type: Article

References (63)

1. Arai, T., Akiyama, Y., Okabe, S., Ando, M., Endo, M., and Yuasa, Y. (1998). Genomic structure of human Smad3 gene and its infrequent alterations in colorectal cancers. Cancer Lett. 122, 157-163.
2. Baker, J.C., and Harland, R.M. (1996). A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10, 1880-1889.
3. Brannan, C., Perkins, A., Vogel, K., Ratner, N., Nordlund, M., Reid, S., Buchberg, A., Jenkins, N., Parada, L., and Copeland, N. (1994). Targeted disruption of the neurofibromatosis type-1 gene leads to abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8, 1019-1029.
4. Bresalier, R., and Kim, Y. (1998). Malignant neoplasms of the large intestine. In Sleisenger and Fordtran's Gastrointestinal and Liver Disease, M. Feldman, B. Scharschmidt, and M. Sleisenger, eds. (Philadelphia: W.B. Saunders and Company), pp. 1906-1942.
5. Bronner, C., Baker, S., Morrison, P., Warren, G., Smith, L., Lescoe, M., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994). Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368, 258-261.
6. Candia, A., Watabe, T., Hawley, S., Onichtchouk, D., Zhang, Y., Derynck, R., Niehrs, C., and Cho, C. (1997). Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/ BVg1 and BMP-2/4 signaling mediated by Smads. Development 124, 4467-4480.
7. Clarke, A., Maandag, E., van Roon, M., van der Lugt, N., van der Valk, M., Hooper, M., Berns, A., and te Riele, H. (1992). Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330.
8. Cohen, A., Minsky, B., and Schilisky, R. (1997). Cancer of the colon. In Cancer: Principles and Practice of Oncology, V. Devita, S. Hellman, and S. Rosenberg, eds. (Philadelphia: Lippincott-Raven), pp. 1144-1197.
9. Derynck, R. (1994). TGF-β-receptor-mediated signaling. Trends Biol. Sci. 19, 548-553.
10. Derynck, R., and Zhang, Y. (1996). Intracellular signaling: the Mad way to do it. Curr. Biol. 6, 1226-1229.
11. Dickson, M., Martin, J., Cousins, F., Kulkarni, A., Karlsson, S., and Akhurst, R. (1995). Defective haemotopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121, 1845-1854.
12. Dietrich, W., Lander, E., Smith, J., Moser, A., Gould, K., Luongo, C., Borenstein, N., and Dove, W. (1993). Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631-639.
13. Donehower, L., Harvey, M., Slagle, B., McArthur, M., Montgomery, C., Butel, J., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.
14. Eppert, K., Scherer, S., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.C., Bapat, B., Gallinger, S., Andrulis, I., Thomsen, G., Wrana, J., and Attisano, L. (1996). MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 88, 543-552.
15. Fenoglio-Preiser, C., Lantz, P., Listrom, M., Davis, M., and Rilke, F. (1989). Gastrointestinal pathology. (New York: Raven Press).
16. Graff, J. (1997). Embryonic patterning: to BMP or not to BMP that is the question. Cell 89, 171-174.
17. Graff, J., Bansal, A., and Melton, D. (1996). Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85, 479-487.
18. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spiro, L., Robertson, M., et al. (1991). Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589-600.
19. Heldin, C., Miyazono, K., and ten Dijke, P. (1997). TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
20. Hogan, B., Beddington, R., Constantini, F., and Lacy, E. (1994). Manipulating the Mouse Embryo (New York: Cold Spring Harbor Press).
21. Ionov, Y., Peinado, M., Malkhosyan, S., Shibata, D., and Perucho, M. (1993). Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558-561.
22. Jacks, T., Fazeli, A., Schmitt, E., Bronson, R., Goodell, M., and Weinberg, R. (1992). Effects of an Rb mutation in the mouse. Nature 359, 295-300.
23. Jacks, T., Remington, L., Williams, B., Schmitt, E., Halachmi, S., Bronson, R., and Weinberg, R. (1994a). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
24. Jacks, T., Shih, T., Schmitt, E., Bronson, R., Bernards, A., and Weinberg, R. (1994b). Tumor predisposition in mice heterozygous for a targeted mutation in Nf1. Nat. Genet. 7, 353-361.
25. Jirciny, J. (1994). Colon cancer and DNA repair: have mismatches met their match? Trends Genet. 10, 164-168.
26. Kaartinen, V., Voncken, J., Shuler, C., Warburton, D., Bu, D., Heisterkamp, N., and Groffen, J. (1995). Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11, 415-421.
27. Kinzler, K., and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-170.
28. Krieg, P.A., Varnum, S., Wormington, M., and Melton, D.A. (1989). The mRNA encoding elongation factor 1α (EF-1α) is a major transcript at the mid blastula transition in Xenopus. Dev. Biol. 133, 93-100.
29. Krull, C., Lansford, R., Gale, N., Collazo, A., Marcelle, C., Yancopoulos, G., Fraser, S., and Bronner-Fraser, M. (1997). Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Curr. Biol. 7, 571-580.
30. Kulkarni, A., Huh, C., Becker, D., Geiser, A., Lyght, M., Flanders, K., Roberts, A., Sporn, M., Ward, J., and Karlsson, S. (1993). TGFβ1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90, 770-774.
31. Leach, F., Nicolaides, N., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomaki, P., Sistonen, P., Aaltonen, L., Nystrom-Lahti, M., et al., (1993). Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75, 1215-1225.
32. Lee, E., Chang, C., Hu, N., Wang, Y., Lai, C., Herrup, K., Lee, W., and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoieses. Nature 359, 288-294.
33. Liu, F., Hata, A., Baker, J., Doody, J., Caracamo, J., Harland, R., and Massague, J. (1996). A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623.
34. Liu, X., Sun, Y., Constantinescu, S., Karam, E., Weinberg, R., and Lodish, H. (1997). Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA 94, 10669-10674.
35. Lu, S., Kawabata, M., Imamura, T., Akiyama, Y., Nomizu, T., Miyazono, K., and Yuasa, Y. (1998). HNPCC associated with germline mutation in the TGFβ type II receptor gene. Nat. Genet. 19, 17-18.
36. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R., Zborowska, E., Kinzler, K., Vogelstein, B., Brattain, M., and Willson, J. (1995). Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338.
37. Massague, J. (1996). TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85, 947-950.
38. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C., Miyazono, K., and ten Dijke, P. (1997a). TGFβ receptor-mediated signaling through Smad2, Smad3, and Smad4. EMBO J. 16, 5353-5362.
39. Nakao, A., Roijer, E., Imamura, T., Souchelnytskyi, S., Stenman, G., Heldin, C., and ten Dijke, P. (1997b). Identification of Smad2, a human Mad-related protein in the TGFβ signaling pathway. J. Biol. Chem. 272, 2896-2900.
40. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., Hedge, P., et al. (1991). Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253, 665-669.
41. Oshima, M., Oshima, H., and Taketo, M. (1996). TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179, 297-302.
42. Δ716 knockout mice. Cancer Res. 57, 1644-1649.
43. Papadopoulos, N., Nicolaides, N., Wei, Y., Ruben, S., Carter, K., Rosen, R., Haseltine, W., Fleischmann, R., Fraser, C., et al. (1994). Mutation of a mutL homolog in hereditary colon cancer. Science 263, 1625-1629.
44. Parsons, R., Li, G., Longley, M., Fang, W., Papadopoulos, N., Jen, J., de la Chapelle, A., Kinzler, K., Vogelstein, B., and Modrich, P. (1993). Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75, 1227-1236.
45. Polyak, K. (1996). Negative regulation of cell growth by TGFβ. Biochim. Biophys. Acta 1242, 185-199.
46. Riggins, G., Kinzler, K., Vogelstein, B., and Thiagalingam, S. (1997). Frequency of Smad gene mutations in human cancers. Cancer Res. 57, 2578-2580.
47. Sanford, L., Ormsby, I., Gittenberger-deGroot, A., Sariola, H., Friedman, R., Biovin, G., Cardell, E., and Doetschman, T. (1997). TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 124, 2659-2670.
48. Schutte, M., Hruban, R., Hedrick, L., Cho, K., Hadasdy, G.,Weinstein, C., Bova, G., Isaacs, W., Cairns, P., Nawroz, H., et al. (1996). DPC4 gene in various tumor types. Cancer Res. 56, 2527-2530.
49. Shull, M., Ormsby, I., Kier, A., Pawlowski, S., Diebold, R., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N., and Doetschman, T. (1992). Targeted disruption of the mouse TGFβ1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
50. Sirard, C., de la Pompa, J., Elia, A., Itie, A., Mirtsos, C., Cheung, A., Hahn, S., Wakehan, A., Schwartz, L., Kern, S., Rossant, J., and Mak, T. (1998). The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12, 107-119.
51. Su, L., Kinzler, K., Vogelstein, B., Preisinger, A., Mosher, A., Luongo, C., Gould, K., and Dove, W. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 658-670.
52. Suzuki, A., Chang, C., Yingling, J., Wang, X., and Hemmati-Brivanlou, A. (1997). Smad5 induces ventral fates in Xenopus embryo. Dev. Biol. 184, 402-405.
53. Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M., and Taketo, M. (1998). Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92, 645-656.
54. Thiagalingam, S., Lengauer, C., Leach, F., Schutte, M., Hahn, S., Overhauser, J., Willson, J., Markowitz, S., Hamilton, S., Kern, S., Kinzler, K., and Vogelstein, B. (1996). Evaluation of chromosome 18q in colorectal cancers. Nat. Genet. 13, 343-346.
55. Tomlinson, I., Ilyas, M., and Novelli, M. (1997). Molecular genetics of colon cancer. Cancer Metastais Rev. 16, 67-79.
56. Waldrip, W., Bikoff, E., Hoodless, P., Wrana, J., and Robertson, E. (1998). Smad2 signaling in extraembryonic tissues determines the anterior-posterior polarity of the early mouse embryo. Cell 92, 797-808.
57. Wang, H., and Anderson, D. (1997). Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron 18, 383-396.
58. Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L., Yang, J., Liang, J., Zbrowska, E., Markowitz, S., Wilson, J., and Brattain, M. (1995). Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem. 270, 22044-22049.
59. White, R. (1998). Tumor suppressing pathways. Cell 92, 591-592.
60. Wick, W., Peterson, I., Schmutzler, R., Wolfarth, B., Lenartz, D., Bierhoff, E., Hummerich, J., Muller, D., Stangl, A., Schramm, J., Wiestler, O., and von Diemling, A. (1996). Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene 12, 973-978.
61. Wrana, J., and Attisano, L. (1996). MAD-related proteins in TGFβ signaling. Trends Genet. 12, 493-496.
62. Yang, X., Li, C., Xu, X., and Deng, C. (1998). The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad. Sci. USA 95, 3667-3672.
63. Zhang, Y., Feng, X., Wu, R., and Derynck, R. (1996). Receptor-associated Mad homologues synergize as effectors of the TGFβ response. Nature 383, 168-172.